Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

32.37
Delayed Data
As of Dec 09
 +5.15 / +18.92%
Today’s Change
24.47
Today|||52-Week Range
41.91
-14.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues168.1M111.0M101.5M142.9M
 
 
 
 
 
Cost of Goods Sold30.3M18.9M26.6M28.8M
 
 
 
 
 
Depreciation And Amortization9.5M8.8M8.9M10.4M
 
 
 
 
 
 
Operating ExpensesGross Income128.3M83.2M66.0M103.7M
 
 
 
 
 
General Expenses78.4M73.8M79.5M67.9M
 
 
 
 
 
Research And Development32.5M34.1M35.3M27.2M
 
 
 
 
 
Total Operating Expenses118.2M101.6M115.0M107.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income49.9M9.4M-13.5M35.8M
 
 
 
 
 
Extraordinary Charge0.00-847.0K-88.0K-328.0K
 
 
 
 
Interest Expense On Debt2.4M2.3M2.3M2.3M
 
 
 
 
 
Other Expenses-524.0K116.0K17.0K-234.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income47.9M7.3M-14.9M33.6M
 
 
 
 
 
Income Taxes-14.5M-3.3M-3.9M-13.2M
 
 
 
 
 
Discontinued Operations0.000.000.00952.0K
 
 
Net Income33.3M4.0M-10.9M21.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.1M39.5M40.2M40.5M
 
 
 
 
 
Shares To Calculate EPS Diluted48.1M48.4M40.2M49.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.71$0.10-$0.27$0.45
 
 
 
 
 
EPS Diluted$0.71$0.10-$0.27$0.45